Meghan R Swanson1, Jason J Wolff2, Mark D Shen3, Martin Styner3,4, Annette Estes5, Guido Gerig6, Robert C McKinstry7, Kelly N Botteron8,9, Joseph Piven3, Heather C Hazlett3. 1. Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill. 2. Department of Educational Psychology, University of Minnesota, Minneapolis. 3. Department of Psychiatry, University of North Carolina at Chapel Hill. 4. Department of Computer Science, University of North Carolina at Chapel Hill. 5. Department of Speech and Hearing Sciences, University of Washington, Seattle. 6. Department of Computer Science and Engineering, New York University, Brooklyn. 7. Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis, Missouri. 8. Department of Psychiatry, Washington University in St Louis, St Louis, Missouri. 9. Department of Radiology, Washington University in St Louis, St Louis, Missouri.
Abstract
Importance: Fragile X syndrome (FXS) is a genetic neurodevelopmental disorder and the most common inherited cause of intellectual disability in males. However, there are no published data on brain development in children with FXS during infancy. Objective: To characterize the development of white matter at ages 6, 12, and 24 months in infants with FXS compared with that of typically developing controls. Design, Setting, and Participants: Longitudinal behavioral and brain imaging data were collected at 1 or more time points from 27 infants with FXS and 73 typically developing controls between August 1, 2008, and June 14, 2016, at 2 academic medical centers. Infants in the control group had no first- or second-degree relatives with intellectual or psychiatric disorders, including FXS and autism spectrum disorder. Main Outcomes and Measures: Nineteen major white matter pathways were defined in common atlas space based on anatomically informed methods. Diffusion parameters, including fractional anisotropy, were compared between groups using linear mixed effects modeling. Fiber pathways showing group differences were subsequently examined in association with direct measures of verbal and nonverbal development. Results: There were significant differences in the development of 12 of 19 fiber tracts between the 27 infants with FXS (22 boys and 5 girls) and the 73 infants in the control group (46 boys and 27 girls), with lower fractional anisotropy in bilateral subcortical-frontal, occipital-temporal, temporal-frontal, and cerebellar-thalamic pathways, as well as 4 of 6 subdivisions of the corpus callosum. For all 12 of these pathways, there were significant main effects between groups but not for the interaction of age × group, indicating that lower fractional anisotropy was present and stable from age 6 months in infants with FXS. Lower fractional anisotropy values in the uncinate fasciculi were correlated with lower nonverbal developmental quotient in the FXS group (left uncinate, F = 10.06; false discovery rate-corrected P = .03; right uncinate, F = 21.8; P = .004). Conclusions and Relevance: The results substantiate in human infants the essential role of fragile X gene expression in the early development of white matter. The findings also suggest that the neurodevelopmental effects of FXS are well established at 6 months of age.
Importance: Fragile X syndrome (FXS) is a genetic neurodevelopmental disorder and the most common inherited cause of intellectual disability in males. However, there are no published data on brain development in children with FXS during infancy. Objective: To characterize the development of white matter at ages 6, 12, and 24 months in infants with FXS compared with that of typically developing controls. Design, Setting, and Participants: Longitudinal behavioral and brain imaging data were collected at 1 or more time points from 27 infants with FXS and 73 typically developing controls between August 1, 2008, and June 14, 2016, at 2 academic medical centers. Infants in the control group had no first- or second-degree relatives with intellectual or psychiatric disorders, including FXS and autism spectrum disorder. Main Outcomes and Measures: Nineteen major white matter pathways were defined in common atlas space based on anatomically informed methods. Diffusion parameters, including fractional anisotropy, were compared between groups using linear mixed effects modeling. Fiber pathways showing group differences were subsequently examined in association with direct measures of verbal and nonverbal development. Results: There were significant differences in the development of 12 of 19 fiber tracts between the 27 infants with FXS (22 boys and 5 girls) and the 73 infants in the control group (46 boys and 27 girls), with lower fractional anisotropy in bilateral subcortical-frontal, occipital-temporal, temporal-frontal, and cerebellar-thalamic pathways, as well as 4 of 6 subdivisions of the corpus callosum. For all 12 of these pathways, there were significant main effects between groups but not for the interaction of age × group, indicating that lower fractional anisotropy was present and stable from age 6 months in infants with FXS. Lower fractional anisotropy values in the uncinate fasciculi were correlated with lower nonverbal developmental quotient in the FXS group (left uncinate, F = 10.06; false discovery rate-corrected P = .03; right uncinate, F = 21.8; P = .004). Conclusions and Relevance: The results substantiate in humaninfants the essential role of fragile X gene expression in the early development of white matter. The findings also suggest that the neurodevelopmental effects of FXS are well established at 6 months of age.
Authors: Jason J Wolff; Guido Gerig; John D Lewis; Takahiro Soda; Martin A Styner; Clement Vachet; Kelly N Botteron; Jed T Elison; Stephen R Dager; Annette M Estes; Heather C Hazlett; Robert T Schultz; Lonnie Zwaigenbaum; Joseph Piven Journal: Brain Date: 2015-05-03 Impact factor: 13.501
Authors: Lars T Westlye; Kristine B Walhovd; Anders M Dale; Atle Bjørnerud; Paulina Due-Tønnessen; Andreas Engvig; Håkon Grydeland; Christian K Tamnes; Ylva Ostby; Anders M Fjell Journal: Cereb Cortex Date: 2009-12-23 Impact factor: 5.357
Authors: E Conti; J Mitra; S Calderoni; K Pannek; K K Shen; A Pagnozzi; S Rose; S Mazzotti; D Scelfo; M Tosetti; F Muratori; G Cioni; A Guzzetta Journal: Hum Brain Mapp Date: 2017-01-17 Impact factor: 5.038
Authors: T A Comery; J B Harris; P J Willems; B A Oostra; S A Irwin; I J Weiler; W T Greenough Journal: Proc Natl Acad Sci U S A Date: 1997-05-13 Impact factor: 11.205
Authors: Heather Cody Hazlett; Michele D Poe; Amy A Lightbody; Guido Gerig; James R Macfall; Allison K Ross; James Provenzale; Arianna Martin; Allan L Reiss; Joseph Piven Journal: J Neurodev Disord Date: 2009-03 Impact factor: 4.025
Authors: Anne C Wheeler; Angela Gwaltney; Melissa Raspa; Katherine C Okoniewski; Elizabeth Berry-Kravis; Kelly N Botteron; Dejan Budimirovic; Heather Cody Hazlett; David Hessl; Molly Losh; Gary E Martin; Susan M Rivera; Jane E Roberts; Donald B Bailey Journal: Pediatrics Date: 2021-05 Impact factor: 7.124
Authors: Carla A Wall; Abigail L Hogan; Elizabeth A Will; Samuel McQuillin; Bridgette L Kelleher; Jane E Roberts Journal: J Neurodev Disord Date: 2019-09-13 Impact factor: 4.025
Authors: Nuria Domínguez-Iturza; Adrian C Lo; Disha Shah; Marcelo Armendáriz; Anna Vannelli; Valentina Mercaldo; Massimo Trusel; Ka Wan Li; Denise Gastaldo; Ana Rita Santos; Zsuzsanna Callaerts-Vegh; Rudi D'Hooge; Manuel Mameli; Annemie Van der Linden; August B Smit; Tilmann Achsel; Claudia Bagni Journal: Nat Commun Date: 2019-08-01 Impact factor: 14.919